Growth Metrics

Bioventus (BVS) Income from Continuing Operations (2020 - 2026)

Bioventus filings provide 6 years of Income from Continuing Operations readings, the most recent being 17318000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 2971.97% to 17318000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 27274000.0, a 157.97% increase, with the full-year FY2025 number at 27274000.0, up 157.97% from a year prior.
  • Income from Continuing Operations hit 17318000.0 in Q4 2025 for Bioventus, up from 4006000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 24528000.0 in Q2 2021 to a low of 101035000.0 in Q4 2022.
  • Median Income from Continuing Operations over the past 5 years was 6114500.0 (2024), compared with a mean of 13708400.0.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 85808.0% in 2022 and later skyrocketed 2971.97% in 2025.
  • Bioventus' Income from Continuing Operations stood at 25000.0 in 2021, then plummeted by 85808.0% to 21477000.0 in 2022, then surged by 64.35% to 7656000.0 in 2023, then soared by 92.12% to 603000.0 in 2024, then skyrocketed by 2971.97% to 17318000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 17318000.0 (Q4 2025), 4006000.0 (Q3 2025), and 9272000.0 (Q2 2025) per Business Quant data.